Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Pathologica ; 110(2): 103-105, 2018 Sep.
Article in English | MEDLINE | ID: mdl-30546146

ABSTRACT

Extraskeletal chondrosarcoma is a rare malignant tumor. The well differentiated histological type, which is found primary in soft tissue, is extremely rare. This report  describes the case of a 58-year-old woman presented with a large palpable mass in the right buttock. Imaging studies revealed a well-defined soft tissue mass, with extensive calcification. A histological examination after surgical resection confirmed the diagnosis of well-differentiated extraosseous chondrosarcoma. The outcome was favorable, without recurrence or metastasis.


Subject(s)
Cell Differentiation , Chondrosarcoma/pathology , Neoplasms, Connective and Soft Tissue/pathology , Biopsy , Buttocks , Chondrosarcoma/diagnostic imaging , Chondrosarcoma/surgery , Diagnosis, Differential , Female , Humans , Magnetic Resonance Imaging , Middle Aged , Neoplasms, Connective and Soft Tissue/diagnostic imaging , Neoplasms, Connective and Soft Tissue/surgery , Predictive Value of Tests , Tomography, X-Ray Computed , Tumor Burden
2.
Cancer Radiother ; 13(1): 37-41, 2009 Jan.
Article in French | MEDLINE | ID: mdl-18703371

ABSTRACT

PURPOSE: Breast mucinous carcinoma is a particular histological form characterized by the extracellular production of mucus. The pure form is rarely reported and its prognostic is better than the other types of the breast cancer. The aim of the present study was to discuss the various anatomoclinical, therapeutic aspects and the prognostic factors of the pure mucinous carcinoma of the breast. PATIENTS AND METHODS: We report seven cases diagnosed over a period of 11 years (1993-2003) in the laboratory of anatomy and pathological cytology of the university hospital of Sfax. A review of the clinical files with immunohistochemistry study (hormonal receptor, synaptophysine, chromogranine, Bcl2, Ki67, P53 and Her-2/neu (C-erbB-2)) were carried out for all the cases. RESULTS: pure colloid carcinoma of the breast accounted for 0,5% of the whole of the breast cancers. The average age of patients was 69 years. At the time of the diagnosis, four tumours were classified T4, one T3, two T2, two N1 and one N3; no patient had presented metastasis (M0) according to pTNM classification. The echomammography showed regular contours mass in four cases. The anatomopathological study showed that the neuroendocrine differentiation was found in two cases, all the tumours had presented positivity for the hormonal receptors (oestrogen and progesterone) and negativity for the other antibodies, two cases exhibited the Bcl2 positivity and negativity for the other antibodies. An adjuvant radiotherapy was carried out for all the patients. The average duration of follow-up was of 33 months; the evolution was marked by the occurrence of metastases in two cases. CONCLUSION: The pure colloid carcinoma of the breast constitutes a particular morphological entity which deserves to be individualized; neuroendocrine differentiation of these tumours must be required. Their forecast is relatively favourable.


Subject(s)
Adenocarcinoma, Mucinous/diagnosis , Breast Neoplasms/diagnosis , Adenocarcinoma, Mucinous/epidemiology , Adenocarcinoma, Mucinous/metabolism , Adenocarcinoma, Mucinous/therapy , Age Distribution , Aged , Biomarkers, Tumor/analysis , Biomarkers, Tumor/metabolism , Breast Neoplasms/epidemiology , Breast Neoplasms/metabolism , Breast Neoplasms/therapy , Chromogranin A/analysis , Female , Humans , Immunohistochemistry , Ki-67 Antigen/analysis , Neoplasm Staging , Prognosis , Radiotherapy, Adjuvant , Rare Diseases , Receptor, ErbB-2/analysis , Receptors, Estrogen/analysis , Receptors, Progesterone/analysis , Retrospective Studies , Synaptophysin/analysis , Tumor Suppressor Protein p53/analysis , Tunisia/epidemiology , Ultrasonography, Mammary
3.
J Gynecol Obstet Biol Reprod (Paris) ; 37(4): 346-52, 2008 Jun.
Article in French | MEDLINE | ID: mdl-18406542

ABSTRACT

INTRODUCTION: Breast metastases are rare. They represent 0.4 to 6% of all breast cancers. Our aim is to discuss the means of diagnosis and the clinicopathological features. PATIENTS AND METHODS: We report a retrospective survey of six cases of breast metastases diagnosed over a period of 11 years (1992-2003) in the laboratory of anatomy and pathological cytology of the university hospital of Sfax. The diagnosis was carried on a material of cytoponction in two cases, a biopsy in three cases, a surgery specimen in one case. Immunohistochemical study was performed in four cases. Clinical, therapeutic and evolutionary data were collected from the files of patients. RESULTS: Metastases to the breast constituted 0.43% of all breast cancers. The primary tumors understood a case of gingival-maxillary non-Hodgkin's lymphoma, a case of retroauricular melanoma, a case of soft tissue leiomyosarcoma, a case of uterine choriocarcinoma, a case of rectal neuroendocrine carcinoma and a case of gastric signet cell carcinoma. All patients were women, the middle age was 45.5 years. In three cases the metastases to the breast was concomitant to the diagnosis of the primitive tumour. Clinically it was a nodule in five cases, the size average was 2.3cm, and a subareolar thickening in one case. The mammary involvement was bilateral in two cases. The middle survival after the diagnosis was eight months. CONCLUSION: Metastases to the breast must be distinguished from primary breast cancers whose treatment and outcome are different. A confrontation of clinical and pathological data is recommended for an accurate diagnosis. Immunohistochemical study is of great interest particularly when the breast tumour is revealing the disease.


Subject(s)
Breast Neoplasms/pathology , Breast Neoplasms/secondary , Adult , Breast Neoplasms/mortality , Breast Neoplasms/therapy , Disease Progression , Female , Humans , Middle Aged , Retrospective Studies , Survival Analysis
4.
J Gynecol Obstet Biol Reprod (Paris) ; 34(8): 815-8, 2005 Dec.
Article in French | MEDLINE | ID: mdl-16319775

ABSTRACT

Malignant transformation of struma ovarii is exceptional (less than 1%). The histolological diagnosis of malignancy is difficult especially in the well differentiated forms. Immunohistochemistry is highly contributive in the anaplastic forms. The prognosis is relatively favorable except for the metastatic and undifferentiated forms. We report a case of malignant struma ovarii with metastasis observed in a 65-year-old woman who died rapidly from her disease. In light of this observation, we discuss the diagnositic, management and outcome features of these particular tumors.


Subject(s)
Ovarian Neoplasms/diagnosis , Struma Ovarii/diagnosis , Aged , Antineoplastic Agents/therapeutic use , Fatal Outcome , Female , Humans , Immunohistochemistry , Keratin-7 , Keratins/analysis , Neoplasm Metastasis , Ovarian Neoplasms/pathology , Ovarian Neoplasms/therapy , Radiotherapy , Struma Ovarii/pathology , Struma Ovarii/therapy , Thyroglobulin/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...